Immune Pharmaceuticals' Oncology Subsidiary, Cytovia, Announces Addl. Clinical Trial Results on the Efficacy of Ceplene® in Combination Low-Dose IL-2 in Patients With Acute Myeloid Leukemia, Recently Published in Leukemia, a Leading Hematology Journal
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.